Defibtech Battery Pack Recall May Affect Lifeline and ReviveR AEDs

More than 5,400 Defibtech rechargeable defibrillator battery packs are being recalled due to a defect that may result in the batteries not providing the power for life-saving electric shocks when needed. 

The Defibtech defibrillator battery recall was announced on June 9 by FDA, following a June 3 announcement by the Defibtech, LLC. The batteries are in use in Lifeline AED and ReviveR AED semi-automatic external defibrillators (AED).  

In certain cases, when the battery is connected to the AED, the device may falsely detect an error while charging up to provide a shock to the patient and then deactivate the charge. The company has received at least four reports of this malfunction occurring when patients needed defibrillation. Defibtech did not indicate whether the patients in those situations recovered.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

The FDA has classified the defibrillator recall as a Class 1 Medical Device Recall, meaning that the defect is likely to result in serious injury or death. It is the most serious form of medical device recall.

According to Defibtech, the defect involves 5,418 DBP-2800 Battery Packs shipped before June 4, 2007. “Lifeline AED” or “ReviveR AED” is printed on the front of the affected devices. The battery packs were distributed worldwide to emergency services providers, schools, health clubs and other organizations.

The company has said it has mailed recommendations to customers on how to use the AEDs with the defective batteries, until the battery pack can be replaced. The company will provide free repair kit to customers. For more information, customers can go to www.defibtech.com/batteryFA.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

Plaintiffs have asked the judge presiding over all AFFF lawsuits to consolidate five claims involving kidney cancer and testicular cancer injuries for the first bellwether trial in the federal MDL.
As sportsbooks have spread to 38 states, new data shows a sharp rise in gambling addiction-related help-seeking, suggesting that the platforms’ predatory designs may be fueling harmful, compulsive behaviors.
A product liability lawsuit over the side effects of the Depo shot states women worldwide were warned about brain tumor risks, but not those in the U.S.